Compare ACH & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACH | LNSR |
|---|---|---|
| Founded | 1882 | 2004 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | | Medical Electronics |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.3M | 146.7M |
| IPO Year | N/A | 2005 |
| Metric | ACH | LNSR |
|---|---|---|
| Price | $2.37 | $11.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.0M | 39.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,494,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.87 |
| 52 Week Low | $1.84 | $8.96 |
| 52 Week High | $2.80 | $17.31 |
| Indicator | ACH | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 61.57 | 32.53 |
| Support Level | $2.17 | $12.05 |
| Resistance Level | $2.52 | $12.61 |
| Average True Range (ATR) | 0.20 | 0.39 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 85.71 | 4.92 |
Accendra Health Inc is a world-wide healthcare solutions company providing essential products, services and technology solutions that support care delivery in hospitals, health systems and research centers around the world.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.